Ally Bridge Group
Out of Scope
Bio
Ally Bridge Group Ally Bridge Group was founded in 2013 by Frank Yu, operating from dual offices in New York and Hong Kong. The firm has led or co-led over $6B in transactions across healthcare subsectors, running a dual strategy: private equity (since 2013) and long- biased public equity (since 2018). The focus is US, European, and Chinese healthcare markets at growth, late-stage, and buyout. positioning Ally Bridge as a bridge between global capital and China healthcare opportunities. The por
Industries
BiotechMedTech
Stages
Series ASeries B+
Geography
USEuropeChina
Notable investments
- WuXi AppTec
- Grail
- Shockwave Medical
- Innovent Biologics